The system can efficiently erase long stretches of DNA from a targeted site in the human genome

Flow cytometry applications in development aim to isolate cells for immunotherapy and regenerative medicine

Clinical utility and cost-effectiveness are key considerations

Genetically modified microbes designed to treat human disease have entered into preclinical and clinical development

Forty percent of patients with diffuse large B-cell lymphoma had a complete response, most of which were durable

Genetically driven MDS enabled by gene linked to metabolism and oxygen in cells